Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Wilson Edward B — AKESIS PHARMACEUTICALS, INC. insider: 1 transactions · InsiderLens

Home / Insiders / Wilson Edward B

Wilson Edward B

Director at AKESIS PHARMACEUTICALS, INC. · on record since Dec 21, 2004
President & CEO at AKESIS PHARMACEUTICALS, INC. · on record since Jan 25, 2005

Insider trading activity of Wilson Edward B

Transactions on record: 1; since Jan 25, 2005

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jan 25, 2005

Figures computed from official regulatory filings — methodology.

Companies where Wilson Edward B has traded

AKESIS PHARMACEUTICALS, INC.1 tx · Jan 25, 2005

Track record of Wilson Edward B

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Wilson Edward B

Co-insiders of Wilson Edward B

Avalon Ventures VII L PAKESIS PHARMACEUTICALS, INC.
Fine Floree RAKESIS PHARMACEUTICALS, INC.
Fine Stuart AAKESIS PHARMACEUTICALS, INC.
Hendrick John TAKESIS PHARMACEUTICALS, INC.
Joy KellyAKESIS PHARMACEUTICALS, INC.
Keeling Gary RAKESIS PHARMACEUTICALS, INC.
Kinsella Kevin JAKESIS PHARMACEUTICALS, INC.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

LeBel CarlAKESIS PHARMACEUTICALS, INC.

Lichter JayAKESIS PHARMACEUTICALS, INC.

SAYER KEVIN RAKESIS PHARMACEUTICALS, INC.

SFLL Fine Family Investments Partnership, L.P.AKESIS PHARMACEUTICALS, INC.

STEEL JOHN F IVAKESIS PHARMACEUTICALS, INC.

Company	Filed	Type	Qty	Price	Value · USD	Src
AKESIS PHARMACEUTICALS, INC.	Jan 25, 2005	AwardD	862,499	0.00 USD	—	SEC